Apple
AAPL
Taylor Morrison Home
TMHC
D.R. Horton
DHI
4
Petroleo Brasileiro SA Petrobras
PBR
5
Vale SA
VALE
US Stock MarketDetailed Quotes
SRPT Sarepta Therapeutics
- 71.810
- -1.070-1.47%
Close Mar 27 16:00 ET
- 72.000
- +0.190+0.26%
Pre 08:43 ET
6.97BMarket Cap30.69P/E (TTM)
73.950High71.250Low1.36MVolume72.980Open72.880Pre Close98.29MTurnover1.48%Turnover Ratio30.69P/E (Static)97.03MShares173.25052wk High4.56P/B6.65BFloat Cap70.91052wk Low--Dividend TTM92.55MShs Float181.830Historical High--Div YieldTTM3.71%Amplitude2.598Historical Low72.005Avg Price1Lot Size
Sarepta Therapeutics News
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nicaise Claude
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Boor Kathryn Jean
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Connelly Deirdre P
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chambers Michael Andrew
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rothfuss Cristin
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wigzell Hans Lennart Rudolf
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mayo Stephen
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barry Richard
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arif Bilal
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nicaise Claude
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murray Dallan
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BEHRENS M KATHLEEN
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodino-Klapac Louise
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arif Bilal
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rothfuss Cristin
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murray Dallan
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rothfuss Cristin
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arif Bilal
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murray Dallan
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025